In individuals with specific malignancies, including as head and neck squamous cell carcinoma and lung adenocarcinoma, a combination of inhibitors has been shown to reduce tumour growth and prevent relapse. Their findings encourage the creation of novel therapy modalities that specifically t
The therapy, tested in mouse models, combines a delivery system that targets cancer cells with a specially modified version of microRNA-34a, a molecule that acts “like the brakes on a car,” slowing or stopping cell division, said Andrea Kasinski, lead author and the William and Patty Miller
Treatment for over 80 per cent of breast cancer survivors does not end with surgery, radiation, and chemotherapy. Instead, doctors advise them to take medication to inhibit sex hormones, which can fuel tumour growth and cause recurrence, for the next five to ten years.
Researchers at the University of Florida College of Medicine have uncovered how typical ageing-related blood system alterations can cause some colon tumours to spread more quickly.
Researchers have conducted an in-depth examination of the proteins responsible for cancer across a variety of tumour types, providing knowledge that cannot be determined only by genome sequencing
A new mechanism has been discovered to explain why some prostate tumours move from a common, treatable form to a more rare and severe form of prostate cancer, according to a study from the University of Michigan Rogel Cancer Centre.
Sanford Burnham Prebys' recent study has contributed to the understanding of how melanoma circumvents the immune system and may help in the development of future treatments for the condition. A protein that is known to be active in immune cells is also active inside melanoma cells, the study
Cancer cells with extra chromosomes rely on those chromosomes for tumour growth, according to a new Yale study, and removing them inhibits the cells from becoming tumours. According to the researchers, the findings show that specifically targeting additional chromosomes may offer a novel app
Researchers discovered that cancer frequently sends substances into the bloodstream that pathologically alter the liver, putting it in an inflammatory condition, causing fat to build up, and interfering with its regular detoxification functions.
Researchers at Weill Cornell Medicine found that cancer often releases molecules into the bloodstream that pathologically modify the liver, sending it into an inflammatory state, causing fat accumulation, and disrupting its typical detoxification processes. This finding sheds light on one of
Brain cancer is a difficult-to-treat disease. As it progresses, glioblastoma destroys a person's mental skills, yet the tumor's insidious ability to penetrate neighbouring networks in the brain might also prove its undoing.
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.